Microenvironment-mediated resistance to anticancer therapies
Resistance to molecularly targeted therapies can result from genomic alterations in the tumor cells that reactivate oncogenic signaling.Less is known of tumor ceil-extrinsic mechanisms of resistance to targeted therapies.Two recent studies have identified HGF as a soluble factor capable of mediating resistance to BRAF and HER2 inhibitors in a paracrine manner.These new findings suggest an important role for the tumor microenvironment in mediating resistance to molecularly targeted therapies.
23
2013-04-08(万方平台首次上网日期,不代表论文的发表时间)
共3页
179-181